ID26335A - Metoda untuk mencegah restenosis dengan menggunakan tokotrienol - Google Patents

Metoda untuk mencegah restenosis dengan menggunakan tokotrienol

Info

Publication number
ID26335A
ID26335A IDW20001179A ID20001179A ID26335A ID 26335 A ID26335 A ID 26335A ID W20001179 A IDW20001179 A ID W20001179A ID 20001179 A ID20001179 A ID 20001179A ID 26335 A ID26335 A ID 26335A
Authority
ID
Indonesia
Prior art keywords
tokotrienol
preventing restenosis
restenosis
preventing
Prior art date
Application number
IDW20001179A
Other languages
English (en)
Inventor
Ronald H Lane
F Howard Schneider
Original Assignee
Lipogenic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogenic Inc filed Critical Lipogenic Inc
Publication of ID26335A publication Critical patent/ID26335A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Prostheses (AREA)
IDW20001179A 1997-11-17 1998-11-17 Metoda untuk mencegah restenosis dengan menggunakan tokotrienol ID26335A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97170397A 1997-11-17 1997-11-17

Publications (1)

Publication Number Publication Date
ID26335A true ID26335A (id) 2000-12-14

Family

ID=25518699

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001179A ID26335A (id) 1997-11-17 1998-11-17 Metoda untuk mencegah restenosis dengan menggunakan tokotrienol

Country Status (6)

Country Link
EP (1) EP1037628A4 (id)
JP (1) JP2001522880A (id)
AU (1) AU746369B2 (id)
CA (1) CA2310232A1 (id)
ID (1) ID26335A (id)
WO (1) WO1999025336A1 (id)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2346181T3 (es) * 2000-03-31 2010-10-13 EISAI R&D MANAGEMENT CO., LTD. Uso de gamma-tocotrienol como diuretico.
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US7803149B2 (en) 2002-07-12 2010-09-28 Cook Incorporated Coated medical device
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
CN1897891A (zh) 2003-10-21 2007-01-17 医学技术设备公司 预防再狭窄的γ－生育酚疗法
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036982A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Drug delivery coating for use with a stent
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1811933B1 (en) 2004-09-28 2016-03-23 Atrium Medical Corporation Barrier layer
PT2471530T (pt) 2005-06-01 2017-04-19 Edison Pharmaceuticals Inc Produtos terapêuticos com atividade redox para o tratamento de doenças mitocondriais e de outras condições e modulação de biomarcadores energéticos
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
WO2007047781A2 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
EP1986636B1 (en) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
EP2083875B1 (en) 2006-11-06 2013-03-27 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
US8314153B2 (en) 2008-09-10 2012-11-20 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
US10369256B2 (en) 2009-07-10 2019-08-06 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon
WO2011008393A2 (en) 2009-07-17 2011-01-20 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
SI2470168T1 (en) 2009-08-26 2018-05-31 Bioelectron Technology Corporation Procedures for the prevention and treatment of brain ischemia
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
CN104837488A (zh) * 2012-07-19 2015-08-12 俄亥俄州立大学 改善凝血病变的方法以及相关材料和方法
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07504887A (ja) * 1991-11-22 1995-06-01 リポジェニックス，インコーポレイテッド トコトリエノールおよびトコトリエノール様化合物ならびにこれらを使用する方法
DE4333794A1 (de) * 1993-10-04 1995-04-06 Carl Heinrich Dr Weischer Neue Acetyl-Salicylsäure-Derivate zur Bekämpfung von Entzündungs- und Schmerzzuständen sowie zur Thromboseprophylaxe und -terapie
EP0669132A1 (en) * 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Pharmaceutical composition of vitamin E and acetylsalicylate for treatment and prevention of atherosclerosis

Also Published As

Publication number Publication date
WO1999025336A1 (en) 1999-05-27
EP1037628A1 (en) 2000-09-27
EP1037628A4 (en) 2002-08-21
JP2001522880A (ja) 2001-11-20
CA2310232A1 (en) 1999-05-27
AU746369B2 (en) 2002-04-18
AU1590299A (en) 1999-06-07

Similar Documents

Publication Publication Date Title
ID26335A (id) Metoda untuk mencegah restenosis dengan menggunakan tokotrienol
IS8368A (is) Ný aðferð
FI971067L (fi) Menetelmä muistin toteuttamiseksi
FI971065A7 (fi) Menetelmä muistin toteuttamiseksi
DE69830295D1 (de) Steuerungsverfahren
FI972024L (fi) Kanavanvaihtomenetelmä
ATE235220T1 (de) Resorcinderivate
ATE260243T1 (de) N-aroylphenylalaninderivate
EE03801B1 (xx) Stent
FI971620A7 (fi) Autentikointimenetelmä
DE69817186D1 (de) Diaminorhodamin-derivate
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
FI971066A7 (fi) Menetelmä muistin toteuttamiseksi
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
ATE440854T1 (de) 5-deoxy-cytidin-derivate
DE69815975D1 (de) Steuerungsverfahren
IS5106A (is) Ný aðferð
NO20003079D0 (no) Polymerisasjon-oppstartningsprosess
DE69816734D1 (de) Steuerungsverfahren
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
NO20003080D0 (no) Polymerisasjon-oppstartningsprosess
FI972108A7 (fi) Menetelmä parametrien siirtämiseksi
DE69828780D1 (de) Amidinocamptpthecin-derivate
FI974067A0 (fi) Process foer cellulasbehandling
FI981242A0 (fi) Menetelmä kefalokuvien ottamiseksi